Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib
Actas Dermosifiliogr (Engl Ed). 2019 Dec;110(10):863-865.
doi: 10.1016/j.ad.2018.05.022.
Epub 2019 Sep 9.
[Article in
English,
Spanish]
Affiliations
- 1 Departamento de Dermatología, Hospital de Santarém EPE, Santarém, Portugal. Electronic address: anafilipemonteiro@gmail.com.
- 2 Departamento de Dermatología, Hospital de Santarém EPE, Santarém, Portugal.
- 3 Departamento de Cirugía Plástica, Centro Hospitalar de Lisboa Ocidental EPE, Lisboa, Portugal.
No abstract available
MeSH terms
-
Aged, 80 and over
-
Anilides / therapeutic use*
-
Carcinoma, Basal Cell / drug therapy*
-
Carcinoma, Basal Cell / pathology
-
Eyelid Neoplasms / drug therapy*
-
Eyelid Neoplasms / pathology
-
Humans
-
Male
-
Neoadjuvant Therapy
-
Pyridines / therapeutic use*
Substances
-
Anilides
-
HhAntag691
-
Pyridines